The HSP90AA1 antibody targets the heat shock protein 90 alpha family class A member 1 (HSP90AA1), a molecular chaperone critical for maintaining cellular homeostasis under stress. HSP90AA1. part of the HSP90 family, facilitates the folding, stabilization, and activation of client proteins, including kinases, transcription factors, and steroid hormone receptors. It plays a pivotal role in stress response, cell signaling, and cancer progression, as many client proteins are oncogenic. Dysregulation of HSP90AA1 is linked to tumorigenesis, neurodegenerative diseases, and inflammatory conditions, making it a therapeutic target.
HSP90AA1 antibodies are essential tools for studying its expression, localization, and interactions. They are widely used in techniques like Western blotting, immunohistochemistry (IHC), immunoprecipitation (IP), and immunofluorescence (IF) to investigate HSP90AA1's role in disease mechanisms. Specific antibodies can distinguish between HSP90 isoforms (e.g., HSP90α vs. HSP90β) or detect post-translational modifications (e.g., phosphorylation, acetylation) that regulate its activity. Researchers also utilize these antibodies to evaluate the efficacy of HSP90 inhibitors in preclinical cancer models. Monoclonal antibodies, such as those targeting the N-terminal ATP-binding domain, are commonly employed for functional studies, while polyclonal antibodies offer broader epitope recognition. Validating antibody specificity using knockout controls is crucial due to high homology among HSP90 family members. Overall, HSP90AA1 antibodies are indispensable for advancing research in molecular chaperone biology and therapeutic development.